Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients

References

• Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415–7419.
   PubMed Web of Science ®Google Scholar
• Gallo RC. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology 2005;2:17.
   PubMed Web of Science ®Google Scholar
• Uchiyama T, Yodoi J, Sagawa K, et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481–492.
   PubMed Web of Science ®Google Scholar
• Takatsuki K. Discovery of adult T-cell leukemia. Retrovirology 2005;2:16.
   PubMed Web of Science ®Google Scholar
• Tsukasaki K, Utsunomiya A, Fukuda H, et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007;25: 5458–5464.
   PubMed Web of Science ®Google Scholar
• Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005;24:6058–6068.
   PubMed Web of Science ®Google Scholar
• Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer 1990;45:237–243.
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007;7:270–280.
   PubMed Web of Science ®Google Scholar
• Arnulf B, Thorel M, Poirot Y, et al. Loss of the ex vivo but not the reinducible CD8 + T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma. Leukemia 2004;18:126–132.
   PubMed Web of Science ®Google Scholar
• Kannagi M, Harashima N, Kurihara K, et al. Tumor immunity against adult T-cell leukemia. Cancer Sci 2005;96:249–255.
   PubMed Web of Science ®Google Scholar
• Kozako T, Arima N, Toji S, et al. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8 + T cell in adult T cell leukemia patients. J Immunol 2006;177:5718–5726.
   PubMed Web of Science ®Google Scholar
• Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 2013;13:227–242.
   PubMed Web of Science ®Google Scholar
• Kozako T, Yoshimitsu M, Fujiwara H, et al. PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. Leukemia 2009;23:375–382.
   PubMed Web of Science ®Google Scholar
• Ezinne CC, Yoshimitsu M, White Y, et al. HTLV-1 specific CD8 + T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infection. PLoS One 2014;9:e87631.
   PubMed Web of Science ®Google Scholar
• Chibueze CE, Yoshimitsu M, Arima N. CD160 expression defines a uniquely exhausted subset of T lymphocytes in HTLV-1 infection. Biochem Biophys Res Commun 2014;453:379–384.
   PubMed Web of Science ®Google Scholar
• Hamid O, Robert C, Daud A, et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med 2013;369: 134–144.
   PubMed Web of Science ®Google Scholar
• Wolchok JD, Kluger H, Callahan MK, et al. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med 2013;369:122–133.
   PubMed Web of Science ®Google Scholar
• Topalian SL, Sznol M, McDermott DF, et al. Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol 2014;32:1020–1030.
   PubMed Web of Science ®Google Scholar
• Nolte MA, van Olffen RW, van Gisbergen KP, et al. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 2009;229:216–231.
   PubMed Web of Science ®Google Scholar
• Baba M, Okamoto M, Hamasaki T, et al. Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells. J Virol 2008;82:3843–3852.
   PubMed Web of Science ®Google Scholar
• Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Haematol 1991;79:428–437.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Yoshida A, Tozawa H, et al.Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen. Int J Cancer 1991;48:623–630.
   PubMed Web of Science ®Google Scholar
• Arima N, Molitor JA, Smith MR, et al. Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation. J Virol 1991;65:6892–6899.
   PubMed Web of Science ®Google Scholar
• Takemoto S, Matsuoka M, Yamaguchi K, et al.A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction. Blood 1994;84:3080–3085.
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 2013;48: 452–458.
   PubMed Web of Science ®Google Scholar
• Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol 2005;17:275–281.
   PubMed Web of Science ®Google Scholar
• Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003;17:1881–1888.
   PubMed Web of Science ®Google Scholar
• De Milito A, Nilsson A, Titanji K, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004;103:2180–2186.
   PubMed Web of Science ®Google Scholar
• Widney D, Gundapp G, Said JW, et al. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin Immunol 1999;93:114–123.
   PubMed Web of Science ®Google Scholar
• Diegmann J, Junker K, Gerstmayer B, et al. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry. Eur J Cancer 2005;41:1794–1801.
   PubMed Web of Science ®Google Scholar
• Junker K, Hindermann W, von Eggeling F, et al. CD70: a new tumor specific biomarker for renal cell carcinoma. J Urol 2005;173: 2150–2153.
   PubMed Web of Science ®Google Scholar
• Chahlavi A, Rayman P, Richmond AL, et al. Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70. Cancer Res 2005;65:5428–5438.
   PubMed Web of Science ®Google Scholar
• Wischhusen J, Jung G, Radovanovic I, et al. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. Cancer Res 2002;62:2592–2599.
   PubMed Web of Science ®Google Scholar
• Takeda S, Maeda M, Morikawa S, et al. Genetic and epigenetic inactivation of Tax gene in adult T-cell leukemia cells. Int J Cancer 2004;109:559–567.
   PubMed Web of Science ®Google Scholar
• Dassouki Z, Sahin U, Hajj HE, et al. ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation. Blood 2015;125:474–482.
   PubMed Web of Science ®Google Scholar